MDxHealth SA (NASDAQ:MDXH) Short Interest Update

MDxHealth SA (NASDAQ:MDXHGet Free Report) was the target of a large drop in short interest in December. As of December 15th, there was short interest totalling 24,600 shares, a drop of 36.8% from the November 30th total of 38,900 shares. Based on an average trading volume of 153,400 shares, the days-to-cover ratio is presently 0.2 days. Currently, 0.1% of the company’s stock are short sold.

MDxHealth Stock Performance

Shares of MDXH opened at $2.31 on Monday. MDxHealth has a 1 year low of $1.55 and a 1 year high of $4.64. The company has a debt-to-equity ratio of 3.14, a current ratio of 1.54 and a quick ratio of 1.45. The stock’s fifty day moving average price is $2.04 and its two-hundred day moving average price is $2.40. The firm has a market cap of $3.60 million, a PE ratio of -1.52 and a beta of 1.42.

Analysts Set New Price Targets

MDXH has been the topic of a number of analyst reports. Lake Street Capital began coverage on MDxHealth in a research note on Thursday, October 31st. They issued a “buy” rating and a $7.00 target price on the stock. Piper Sandler reduced their price objective on MDxHealth from $8.00 to $6.00 and set an “overweight” rating for the company in a research note on Thursday, November 7th.

Read Our Latest Stock Analysis on MDXH

Institutional Investors Weigh In On MDxHealth

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. OneDigital Investment Advisors LLC increased its stake in shares of MDxHealth by 15.3% in the third quarter. OneDigital Investment Advisors LLC now owns 57,726 shares of the company’s stock worth $120,000 after purchasing an additional 7,656 shares in the last quarter. Maven Securities LTD bought a new position in MDxHealth in the 3rd quarter worth approximately $208,000. Perkins Capital Management Inc. grew its stake in MDxHealth by 70.7% in the 3rd quarter. Perkins Capital Management Inc. now owns 747,375 shares of the company’s stock valued at $1,555,000 after buying an additional 309,500 shares in the last quarter. Finally, MVM Partners LLC raised its holdings in MDxHealth by 3.3% during the 3rd quarter. MVM Partners LLC now owns 4,700,457 shares of the company’s stock valued at $9,706,000 after acquiring an additional 150,000 shares during the period.

About MDxHealth

(Get Free Report)

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. Its testing solutions includes Select mdx, a non-invasive urine test for prostate cancer that measures the expression of two mRNA cancer-related biomarkers; Confirm mdx for prostate cancer tissue test that validates epigenetic test that guides the detection of occult prostate cancer on a patient's previously biopsied negative tissue; and Resolved mdx for urinary tract infection that identifies personalized effective antibiotic options against the patient's infection.

Read More

Receive News & Ratings for MDxHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MDxHealth and related companies with MarketBeat.com's FREE daily email newsletter.